Heparin
- PDF / 169,240 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 34 Downloads / 162 Views
1 S
Heparin-induced thrombocytopenia: 2 case reports In a retrospective study involving 18 patients with active systemic vasculitis (study duration 1994 to 2019), two patients [ages and sexes not stated] were described, who developed heparin-induced thrombocytopenia during treatment with heparin for the active systemic vasculitis. The patients were diagnosed with systemic vasculitis. One patient was positive for both anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane antibodies, while the other patient was negative for both anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane antibodies. Subsequently, both the patients started receiving heparin [indications, dosages and routes not stated]. However, both the patients developed heparin-induced thrombocytopenia[duration of treatment to reactions onset and outcomes not stated]. Boni F, et al. Heparin-induced thrombocytopenia (HIT): A possible cause of venous thromboembolism in active systemic vasculitis. Nephrology Dialysis Transplantation 35 803520244 (Suppl. 3): iii553 abstr. P0248, Jun 2020. Available from: URL: http://doi.org/10.1093/ndt/gfaa142.P0248 [abstarct]
0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Dec 2020 No. 1834
